Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    5,5-Diphenylhydantoin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 32Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Parnell Launches Pentobarbital-Phenytoin Euthanasia for Dogs
    Parnell Launches Pentobarbital-Phenytoin Euthanasia for Dogs

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303495750/en/Parnell-Launches-Pentobarbital-Sodium-and-Phenytoin-Sodium-Euthanasia-Solution-for-Dogs

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    Mankind’s Generics Extended Phenytoin Na Receives Approval In US
    Mankind’s Generics Extended Phenytoin Na Receives Approval In US

    02 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219773

    FDA
    02 Jan 2026
    Share Share
    Enforcement Report - Week of June 21, 2023
    Enforcement Report - Week of June 21, 2023

    21 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-21-2023-14473.pdf

    FDA
    21 Jun 2023
    Share Share
    Enforcement Report - Week of November 30, 2022
    Enforcement Report - Week of November 30, 2022

    30 Nov 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-30-2022-40173.pdf

    FDA
    30 Nov 2022
    Share Share
    Morton Grove's Withdrawal of Approval of 21 Abbreviated New Drug Applications
    Morton Grove's Withdrawal of Approval of 21 Abbreviated New Drug Applications

    02 Dec 2019

    // FEDERALREGISTER

    https://www.federalregister.gov/documents/2019/12/02/2019-25946/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug

    FEDERALREGISTER
    02 Dec 2019
    Share Share
    Lupin`s Generic Phenytoin Sodium Receives Approval in US
    Lupin`s Generic Phenytoin Sodium Receives Approval in US

    01 Oct 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211633

    FDA
    01 Oct 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.